Simavita Limited: Results From 2014 Annual General and Special Meeting

Simavita Limited: Results From 2014 Annual General and Special Meeting

ID: 357065

(firmenpresse) - SYDNEY, AUSTRALIA -- (Marketwired) -- 12/03/14 -- Simavita Limited ("Simavita" or the "Company") (ASX: SVA)(TSX VENTURE: SV) advises that the 2014 Annual General and Special Meeting of shareholders was held at 10.00 am today (Sydney time) at the offices of Dibbs Barker, Level 8, 123 Pitt Street, Sydney, New South Wales, Australia.

All six resolutions that were put before the shareholders were passed on a show of hands.

In respect of resolution 4, in which the Company sought shareholder approval under ASX Listing Rule 7.1A, we confirm that the resolution was passed by a sufficient majority as a special resolution (with 98.44% voting in favour), as set out on the attached page.

The proxy votes received in respect of the various resolutions are set out on the attached page.

For further information, please visit the Company's profile on SEDAR () or the Company's website () or contact the persons outlined below.

About Simavita

Simavita is a medical device company operating in the digital healthcare sector that has developed an innovative, world first solution for the management of urinary incontinence, with a focus on the elderly. The first product is the SIM™ platform technology which is an instrumented incontinence assessment application that provides evidence based incontinence management care plans to the residential aged care market.

About SIM™

SIM™ is a wireless sensor technology that delivers evidence-based instrument incontinence data on individuals. SIM™ provides user friendly tools and software to assess the incontinence condition and to help plan better outcomes. SIM™ is used to detect, record and report incontinence events during a compulsory or recommended assessment period in residential aged care facilities to develop an evidence-based incontinence care plan.

Conducting assessments is mandatory in many countries and the incontinence assessment creates an influential element of care of each individual. For more information on Simavita or SIM™, please visit .





The TSX Venture Exchange has in no way passed upon the merits of the transactions set out herein and has neither approved nor disapproved the contents of this press release. Neither TSX Venture Exchange not its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this Release.

Proxy results for 2014 Annual General and Special Meeting

Notes: The Company currently has a total of 73,727,743 common shares on issue and 849 registered share/CDI holders.



Contacts:
Company
Philippa Lewis
Chief Executive Officer
+61 2 8405 6381

Thomas Howitt
Chief Financial Officer
+ 61 418 351 127

Media and Investor Relations
Buchan Consulting
Annabel Murphy

+61 2 9237 2800


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Fennec Announces Private Placement of Units Nutra Pharma Letter to Shareholders
Bereitgestellt von Benutzer: Marketwired
Datum: 03.12.2014 - 18:00 Uhr
Sprache: Deutsch
News-ID 357065
Anzahl Zeichen: 0

contact information:
Town:

SYDNEY, AUSTRALIA



Kategorie:

Alternative



Diese Pressemitteilung wurde bisher 194 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Simavita Limited: Results From 2014 Annual General and Special Meeting"
steht unter der journalistisch-redaktionellen Verantwortung von

Simavita Limited (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Simavita secures $1.5m in funding ...

SYDNEY, AUSTRALIA -- (Marketwired) -- 05/08/17 -- Simavita Limited ("Simavita" or the "Company") (ASX: SVA) is pleased to announce that as a result of support from new investors and existing shareholders it had raised $1,500,000 ...

Simavita Announces Up to A$2.93 Million Financing Program ...

SYDNEY, AUSTRALIA -- (Marketwired) -- 05/03/17 -- Simavita Limited (Simavita or the Company) (ASX: SVA) today announced a financing program of up to A$2.93 million split between a Placement to institutional and sophisticated investors for A$1.5mill ...

Alle Meldungen von Simavita Limited



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z